Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marcus (MCS) Asset Writedowns and Impairment (2020 - 2025)

Marcus (MCS) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $5.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment fell 18.56% year-over-year to $5.2 million, compared with a TTM value of $12.0 million through Dec 2025, up 52.14%, and an annual FY2025 reading of $5.2 million, down 24.2% over the prior year.
  • Asset Writedowns and Impairment was $5.2 million for Q4 2025 at Marcus, down from $6.4 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $6.4 million in Q4 2024 and bottomed at $377000.0 in Q4 2023.
  • Average Asset Writedowns and Impairment over 5 years is $2.4 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 90.29% in 2021, then soared 1584.62% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $2.0 million in 2021, then fell by 25.02% to $1.5 million in 2022, then tumbled by 75.28% to $377000.0 in 2023, then skyrocketed by 1584.62% to $6.4 million in 2024, then dropped by 18.56% to $5.2 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for MCS at $5.2 million in Q4 2025, $6.4 million in Q4 2024, and $472000.0 in Q2 2024.